Completed NA INTERVENTIONAL 2-arm
NCT03006640
Subcutaneous NTG for US Radial Artery Cannulation (NTG-US-art)
Sponsor: AlRefaey Kandeel
Conditions
Morbid Obesity
Interventions
Subcutaneous nitroglycrin Subcutaneous saline
Updated 4 times since 2017 Last updated: Dec 27, 2016 Started: Jan 31, 2016 Primary completion: Jun 30, 2016 Completion: Nov 30, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on Morbid Obesity, this trial is completed. The trial is conducted by AlRefaey Kandeel and has accumulated 4 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jan 2017 — Jan 2021 [monthly]
Completed NA
First recorded
Jan 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- AlRefaey Kandeel
Data source: Mansoura University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.